Altamira Therapeutics Ltd. Increase Decrease Through Share-based Payment Transactions
Altamira Therapeutics Ltd. (CYTOF) reported Increase Decrease Through Share-based Payment Transactions of $261.47 thousand for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions · last filed 2025-08-29
CHF
| Period end | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|
| 2023-12-31 | 379.41K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 181.28K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 342.80K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 180.81K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 1.21M CHF 20-F/A · filed 2024-04-22 | |
| 2021-06-30 | 1.04M CHF 6-K/A · filed 2023-08-21 | |
| 2020-12-31 | 368.79K CHF 20-F · filed 2023-05-16 | |
| 2020-06-30 | 167.91K CHF 6-K · filed 2021-09-08 | |
| 2019-12-31 | 228.92K CHF 20-F · filed 2022-04-12 | |
| 2019-06-30 | 310.50K CHF 6-K/A · filed 2020-09-17 | |
| 2018-12-31 | 42.76K CHF 20-F · filed 2021-03-31 | |
| 2018-06-30 | -84.75K CHF 6-K · filed 2019-08-15 | |
| 2017-12-31 | 354.85K CHF 20-F · filed 2020-04-16 | |
| 2016-12-31 | 290.78K CHF 20-F · filed 2019-03-14 | |
| 2015-12-31 | 311.67K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Increase Decrease Through Share-based Payment Transactions 6 month | Increase Decrease Through Share-based Payment Transactions 12 month |
|---|---|---|
| 2025-06-30 | $261.47K 6-K · filed 2025-08-29 | |
| 2024-12-31 | $532.08K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $254.29K 6-K · filed 2025-08-29 | |
| 2023-12-31 | $422.27K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $198.79K 6-K · filed 2024-09-24 | |
| 2022-12-31 | $358.95K 20-F · filed 2025-04-30 |